Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.4%

4 terminated/withdrawn out of 90 trials

Success Rate

93.5%

+7.0% vs industry average

Late-Stage Pipeline

29%

26 trials in Phase 3/4

Results Transparency

5 of 58 completed trials have results

Key Signals

7 recruiting5 with results

Enrollment Performance

Analytics

N/A

29(46.0%)

Phase 3

18(28.6%)

Phase 4

8(12.7%)

Phase 2

6(9.5%)

Phase 1

2(3.2%)

63Total

N/A(29)

Phase 3(18)

Phase 4(8)

Phase 2(6)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (90)

Showing 20 of 90 trials

NCT05581212Not ApplicableCompleted

TB Case-Finding, Treatment and Prevention Intervention in Thailand

Role: lead

NCT06503393Completed

SENOVIE France - Therapeutic Mobility and Breast Cancer

Role: lead

NCT05085340Completed

MULTIple Doses of IPTi Proposal: a Lifesaving High Yield Intervention

Role: collaborator

NCT03014167Phase 3Completed

Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH)

Role: collaborator

NCT07281443Not ApplicableActive Not Recruiting

MDA and Targeted Control Against Plasmodium Carriage in the Sahel

Role: lead

NCT07181278Not ApplicableRecruiting

Optimization of Cervical Cancer Screening Strategies Among Women Living With HIV: Effectiveness and Implementation of Decentralized Approach Using a Mobile Team With HPV Testing in the Western Region of Cameroon

Role: lead

NCT06114628Phase 2Recruiting

Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB

Role: collaborator

NCT04409405Completed

Evaluation and Support to EVD Cured Patients and Their Contacts (Les Vainqueurs d'Ebola)

Role: collaborator

NCT07177170Not ApplicableRecruiting

Impact of a Single Versus Multiple Visits on the Cervical Cancer Screening Completeness, Feasibility and Acceptability Among Women Living With HIV in Cameroon

Role: lead

NCT06601712Phase 4Recruiting

Post-discharge Malaria Chemoprevention Implementation Trial in Benin

Role: collaborator

NCT03343431Phase 3Active Not Recruiting

Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B Infection

Role: lead

NCT06136117Completed

Monkeypox, Biology, Outcome, Transmission and Epidemiology -Prospective Follow-up of High-risk Contacts

Role: collaborator

NCT06840860Recruiting

Epidemiological and Pathophysiological Insights Through a Cross-sectional Survey (EPIC)